Voluntary warnings and the limits of good prescribing behavior: the case for de-adoption of meperidine

BACKGROUND: Meperidine (pethidine) offers little to no therapeutic advantage over other opioids, may be more prone to abuse, and produces a neurotoxic metabolite with a long half-life. The Institute for Safe Medication Practices (ISMP) issued warnings in 2004 and 2005 suggesting that meperidine be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Kevin J, Falk, Jamie, Bugden, Shawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687958/
https://www.ncbi.nlm.nih.gov/pubmed/26719721
http://dx.doi.org/10.2147/JPR.S96625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687958/
https://www.ncbi.nlm.nih.gov/pubmed/26719721
http://dx.doi.org/10.2147/JPR.S96625

Ejemplares similares